Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 43

Sort by

Sort Order Select

Journal Articles

Lower Apache II Score and Exchange Transfusions Predict Better Outcomes in the Intensive Care Unit for Patients with Sickle Cell Disease

Renee Cheng, MD, Andrew Srisuwananukorn, MD, Jin Han, Michel Gowhari, DO, Franklin Njoku, MD, Faiz Ahmed Hussain, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-137272

Published: 2020

Journal Articles

Combinatorial Administration of Pharmacological Inhibitors Targeting DNMT1 and KDM1A Produces Synergistic and Additive Increases in F Retiulocytes and γ-Globin Expression in Normal Baboons

Vinzon Ibanez, B.S., Kestis Vaitkus, Robert E. Molokie, MD, Yogenthiran Saunthararajah, MD, Donald Lavelle, PhD

Blood (2020) 136 (Supplement 1): 5.

https://doi.org/10.1182/blood-2020-136599

Published: 2020

Journal Articles

Complications in Pregnancy of Sickle Cell Disease

Avani Singh, MD, Conner Olsen, MD, Xu Zhang, PhD, Robert E. Molokie, MD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-138470

Published: 2020

Journal Articles

Outcomes in Vaso-Occlusive Crisis Treatment in the Emergency Department Vs. Acute Care Observation Center

Renee Cheng, MD, Avani Singh, MD, Xu Zhang, PhD, Priyanka Nasa, Jin Han, Doris Alfaro, Laura Kavoliunaite, Chika Nwachukwu, CNP, Karen Woodard, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Michel Gowhari, DO

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-137297

Published: 2020

Journal Articles

Correction of Point-of-Care International Normalized Ratio (INR) Values in Patients with Sickle Cell Disease

Syeda Rahman, Andrew Srisuwananukorn, MD, Robert E. Molokie, MD, Michel Gowhari, DO, Franklin Njoku, MD, Faiz Ahmed Hussain, MD, Edith A. Nutescu, PharmD., MS, FCCP, Victor R. Gordeuk, MD, Santosh L. Saraf, MD, Jin Han

Blood (2020) 136 (Supplement 1): 34–35.

https://doi.org/10.1182/blood-2020-137166

Published: 2020

Journal Articles

Effects of Hydroxyurea and Renin-Angiotensin Blockade on Kidney Function in Sickle Cell Disease

Jin Han, Andrew Srisuwananukorn, MD, Michel Gowhari, DO, Faiz Ahmed Hussain, MD, Franklin Njoku, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-138753

Published: 2020

Journal Articles

Cancer Incidence and Chemotherapy Tolerance in Patients with Sickle Cell Disease

Mahir Khan, MD, Andrew Srisuwananukorn, MD, Santosh L. Saraf, MD, Faiz Ahmed Hussain, MD, Robert E. Molokie, MD, Michel Gowhari, DO, Victor R. Gordeuk, MD, Franklin Njoku, MD

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-139653

Published: 2020

Journal Articles

Effect of Nicotinamide, 1-Methylnicotinamide, and N'-Methylnicotinamide on Erythroid Colony Formation and γ-Globin Expression in Cultured Baboon CD34+ Cells

Donald Lavelle, PhD, Vinzon Ibanez, B.S., Kestis Vaitkus, Yogenthiran Saunthararajah, MD, Robert E. Molokie, MD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-133974

Published: 2020

Journal Articles

Cathepsin B, a Negative Regulator of Autophagy, Identified As a Novel Therapeutic Drug Target in Sickle Cell Disease

Jagadeesh Ramasamy, PhD, Vinzon Ibanez, B.S., Kareem Al-Qadi, Helen Zhang, Jennifer Afranie-Sakyi, MD, Robert E. Molokie, MD, Donald Lavelle, PhD, Angela Rivers, MD

Blood (2020) 136 (Supplement 1): 32.

https://doi.org/10.1182/blood-2020-140119

Published: 2020

Journal Articles

Risk Factors for Kidney Disease in Hb SC and Hb Sβ + -Thalassemia Sickle Cell Disease

Mandella Mensah, Binal N. Shah, Xu Zhang, PhD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Robert E. Molokie, MD, Mark T Gladwin, MD, Victor R Gordeuk, MD, Santosh L. Saraf, MD

Blood (2019) 134 (Supplement_1): 2299.

https://doi.org/10.1182/blood-2019-128668

Published: 2019

Journal Articles

Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Michel Gowhari, DO, Faiz Ahmed Hussain, MD, Shivi Jain, MD, Laura Kavoliunaite, APN, Robert E. Molokie, MD, Victor R Gordeuk, MD

Blood (2019) 134 (Supplement_1): 3390.

https://doi.org/10.1182/blood-2019-122249

Published: 2019

Journal Articles

Health Care Utilization in Transplanted Versus Non-Transplanted Sickle Cell Disease Patients

Santosh L. Saraf, MD, Krishna Ghimire, MD, Pritesh Patel, MD, Karen Sweiss, PharmD, John G. Quigley, Irum Khan, MBBS, David Peace, MD, Michel Gowhari, DO, Shivi Jain, MD, John P. Galvin, MDMS,MPH, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Damiano Rondelli, MD

Blood (2018) 132 (Supplement 1): 313.

https://doi.org/10.1182/blood-2018-99-113666

Published: 2018

Journal Articles

The Impact of Selenium Deficiency on a Sickle Cell Disease Mouse Model

Ramasamy Jagadeeswaran, PhD, Hong Lenny, PhD, Helen Zhang, Jennifer Afranie-Sakyi, Robert E. Molokie, MD, Donald Lavelle, PhD, Alan Diamond, PhD, Angela Rivers, MD

Blood (2018) 132 (Supplement 1): 3645.

https://doi.org/10.1182/blood-2018-99-111833

Published: 2018

Journal Articles

Protein Phosphorylation Mechanisms Underlying Chronic Pain in Sickle Cell Disease

Ying He, PhD, Diana J. Wilkie, PhD RN, FAAN, Robert E. Molokie, MD, Joseph DeSimone, PhD, Zaijie J. Wang, PhD

Blood (2018) 132 (Supplement 1): 3646.

https://doi.org/10.1182/blood-2018-99-115263

Published: 2018

Journal Articles

Kidney Ultrasound Findings in Sickle Cell Anemia According to Kidney Disease and the APOL1 G1/G2 Risk Variants

Sandra Kang, MD, Rishi Patel, MD, Ali Kord Valeshabad, MD, Binal N. Shah, PhD, Rishabh Choudhari, Dallas De La Vara, Jin Han, PharmD, PhD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Karen Xie, MD, James P. Lash, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2018) 132 (Supplement 1): 3663.

https://doi.org/10.1182/blood-2018-99-113637

Published: 2018

Journal Articles

Pulmonary Function Abnormalities in Adults with Sickle Cell Anemia

Adam Rock, MD, Binal N. Shah, PhD, Jin Han, PharmD, PhD, Rasha Raslan, MD, Michel Gowhari, DO, Shivi Jain, MD, Xu Zhang, PhD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2018) 132 (Supplement 1): 3664.

https://doi.org/10.1182/blood-2018-99-114820

Published: 2018

Journal Articles

Long-Term Stability of the Adult Sickle Cell Quality of Life Measure (ASCQ-Me)

Keesha L. Roach, PhD RN, Yingwei Yao, PhD, Marie L. Suarez, PhD, Veronica Angulo, BS, David Shuey, BS, Miriam O. Ezenwa, PhD RN, Judith M. Schlaeger, PhD CNM, LAc, Roger B. Fillingim, PhD, Zaijie J. Wang, PhD, Robert E. Molokie, MD, Diana J. Wilkie, PhD RN, FAAN

Blood (2018) 132 (Supplement 1): 3576.

https://doi.org/10.1182/blood-2018-99-111158

Published: 2018

Journal Articles

Association of Inpatient Opioid Utilization and Readmission Risk in Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD

Blood (2018) 132 (Supplement 1): 4699.

https://doi.org/10.1182/blood-2018-99-114733

Published: 2018

Journal Articles

Cancer Incidence in Sickle Cell Disease:an Institutional Experience

Shivi Jain, MD, Andrew Srisuwananukorn, MD, Santosh L. Saraf, MD, Xu Zhang, PhD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Robert E. Molokie, MD, Victor R. Gordeuk, MD

Blood (2018) 132 (Supplement 1): 1087.

https://doi.org/10.1182/blood-2018-99-115508

Published: 2018

Journal Articles

Clinical, Laboratory, and Genetic Risk Factors for Thrombosis in Sickle Cell Disease

Andrew Srisuwananukorn, MD, Rasha Raslan, MD, Xu Zhang, PhD, Binal N. Shah, PhD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2018) 132 (Supplement 1): 9.

https://doi.org/10.1182/blood-2018-99-115128

Published: 2018

NARROW

Lower Apache II Score and Exchange Transfusions Predict Better Outcomes in the Intensive Care Unit for Patients with Sickle Cell Disease

Combinatorial Administration of Pharmacological Inhibitors Targeting DNMT1 and KDM1A Produces Synergistic and Additive Increases in F Retiulocytes and γ-Globin Expression in Normal Baboons

Complications in Pregnancy of Sickle Cell Disease

Outcomes in Vaso-Occlusive Crisis Treatment in the Emergency Department Vs. Acute Care Observation Center

Correction of Point-of-Care International Normalized Ratio (INR) Values in Patients with Sickle Cell Disease

Effects of Hydroxyurea and Renin-Angiotensin Blockade on Kidney Function in Sickle Cell Disease

Cancer Incidence and Chemotherapy Tolerance in Patients with Sickle Cell Disease

Effect of Nicotinamide, 1-Methylnicotinamide, and N'-Methylnicotinamide on Erythroid Colony Formation and γ-Globin Expression in Cultured Baboon CD34+ Cells

Cathepsin B, a Negative Regulator of Autophagy, Identified As a Novel Therapeutic Drug Target in Sickle Cell Disease

Risk Factors for Kidney Disease in Hb SC and Hb Sβ + -Thalassemia Sickle Cell Disease

Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease

Health Care Utilization in Transplanted Versus Non-Transplanted Sickle Cell Disease Patients

The Impact of Selenium Deficiency on a Sickle Cell Disease Mouse Model

Protein Phosphorylation Mechanisms Underlying Chronic Pain in Sickle Cell Disease

Kidney Ultrasound Findings in Sickle Cell Anemia According to Kidney Disease and the APOL1 G1/G2 Risk Variants

Pulmonary Function Abnormalities in Adults with Sickle Cell Anemia

Long-Term Stability of the Adult Sickle Cell Quality of Life Measure (ASCQ-Me)

Association of Inpatient Opioid Utilization and Readmission Risk in Sickle Cell Disease

Cancer Incidence in Sickle Cell Disease:an Institutional Experience

Clinical, Laboratory, and Genetic Risk Factors for Thrombosis in Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only